Treatment of Advanced Renal-Cell Carcinoma.

@article{Santini2016TreatmentOA,
  title={Treatment of Advanced Renal-Cell Carcinoma.},
  author={Daniele Santini and Giuseppe Tonini},
  journal={The New England journal of medicine},
  year={2016},
  volume={374 9},
  pages={888-9}
}
To the Editor: In their article on the CheckMate 025 trial, Motzer and colleagues (Nov. 5 issue)1 report that nivolumab, as compared with everolimus, prolonged survival among patients with previously treated advanced renal-cell carcinoma. This trial opens the era of checkpoint inhibitors in renal-cell carcinoma and could help determine the most effective… CONTINUE READING